1. Medtronic received FDA 510(k) clearance and breakthrough device designation for its LigaPass 2.0 ligament augmentation system.
2. The FDA gave an investigational device exemption to devicemaker 3Spine.
3. SeaSpine released its WaveForm C interbody system in a full commercial launch.
3. Medtronic named Lidia Fonseca as an independent director of its board of directors.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.